Prous Institute Presents the Prous Institute – Overton & Meyer Award for New Technologies in Drug Discovery to Prof Gisbert Schneider

On August 29, 2021 Prous Institute for Biomedical Research reported that it is to present the 2020 Prous Institute – Overton & Meyer
Award to Professor Gisbert Schneider, at the XXVI International Symposium on Medicinal Chemistry
organized by the European Federation of Medicinal Chemistry (EFMC) (Press release, Prous Institute, AUG 29, 2021, View Source [SID1234587257]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The award, conferred every two years, recognizes outstanding contributions to the development of new technologies in the field of medicinal chemistry and acknowledges the awardee’s contribution to the discovery and development of innovative technologies that advance the field.

Prof Schneider has pioneered the integration of machine learning into medicinal chemistry, drug discovery and chemical biology. His contributions spread across the whole drug discovery process and introduced visionary concepts for concrete applications of computational methods. These are now broadly adopted in drug discovery and recognized as robust foundations for transformative advancements in the field.

Prof Schneider is Full Professor at ETH Zurich, holding the chair of Computer-Assisted Drug Design and Director of Singapore – ETH Centre.

The award will be presented during the XXVI International Symposium on Medicinal Chemistry (EFMC-ISMC 2021), to be held on August 29 – September 2, 2021. The Award plenary Lecture is scheduled for Sunday, August 29 at 14:00 CET.